Brief: Teoxane SA Announces Superior Proposal To Acquire Revance Therapeutics For $3.60 Per Share In Cash
06/01/2025 14:56
Jan 6 (Reuters) - Revance Therapeutics Inc RVNC.O :
* TEOXANE SA ANNOUNCES SUPERIOR PROPOSAL TO ACQUIRE REVANCE
THERAPEUTICS FOR $3.60 PER SHARE IN CASH
* TEOXANE: PREPARED TO TRANSACT PROMPTLY
* TEOXANE: DOES NOT ANTICIPATE ANY SIGNIFICANT REGULATORY
RISKS OR
DELAYS FOR POTENTIAL REVANCE DEAL
Source text: ID:nPn56bldpa
Further company coverage: RVNC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Revance Therapeutics
See all newsBrief: Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer
Brief: Crown Laboratories And Revance Amend A&R Merger Agreement
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Kratos, Forward Air, Bank stocks
U.S. STOCKS ON THE MOVE-Henry Schein, natgas firms, Citigroup